Tag Archives: The Stem Cell Blog

Will Immunotherapy Be a PANACEA for Breast Cancer? – Medscape

MedscapeWill Immunotherapy Be a PANACEA for Breast Cancer?MedscapeKathy D. Miller, MD: Hi. I am Dr Kathy Miller, professor of medicine at the Indiana University School of Medicine in Indianapolis. Welcome to Medscape Oncology Insights, coming to you fr… Continue reading

Indian scientists have developed a mechanism to rejuvenate aged stem cells – Firstpost

FirstpostIndian scientists have developed a mechanism to rejuvenate aged stem cellsFirstpostThe mechanism developed by researchers at the National Centre for Cell Science (NCCS), Pune involves rejuvenating aged hematopoietic stem cells in a short-term … Continue reading

Cancer Immunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPO – Genetic Engineering & Biotechnology News

San Francisco Business TimesCancer Immunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPOGenetic Engineering & Biotechnology NewsArmo BioSciences, a late-stage developer of cancer immunotherapies, will seek to raise up to $86.25 million i… Continue reading

Sorrento Therapeutics (SRNE) Says it Will Present Potential ‘Game-Changer’ Non-Viral CAR-T Technology for … – StreetInsider.com

Sorrento Therapeutics to Present Potential “Game-Changer” Non-Viral CAR-T Technology for Autologous and … – GlobeNewswire (press release)

Sorrento Therapeutics to Present Potential “Game-Changer” Non-Viral CAR-T Technology for Autologous and …GlobeNewswire (press release)This innovative non-viral CAR-T technology may offer several potential benefits over existing virus-based technology… Continue reading

Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences – PR Newswire (press release)

Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy ConferencesPR Newswire (press release)Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today … Continue reading

NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development – GlobeNewswire (press release)

NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical DevelopmentGlobeNewswire (press release)GAITHERSBURG, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) — NexImmune, an emerging leader in the field of antigen-directed immunoth… Continue reading